3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
Clinical trial NCT02057445 · COMPLETED
Trial details
- NCT number
- NCT02057445
- Sponsor
- New York Medical College
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.